← All diseases

Disease Atlas / Disease detail

Metaphyseal chondrodysplasia

Accessible educational material summarizing the causes, symptoms, diagnosis, management, and research directions of metaphyseal chondrodysplasia.

metaphyseal chondrodysplasia

MONDO:0000138Public QA completeSource-bound · 1

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · c2ab217005df

Disease category
Metaphyseal chondrodysplasia is a group of inherited skeletal disorders involving abnormal development of the metaphyses and growth plates of the long bones.
Core mechanism
This group includes several genetic subtypes, and inheritance patterns and associated features may differ by subtype.
Main causes and associated factors
When the conversion of cartilage to bone in the growth plates and metaphyses is disrupted, abnormalities in bone growth and shape can occur.
Typical manifestations
Typical clinical features may include short stature, bowed legs, skeletal deformities, and stiffness or pain around the joints.
Individual variation
The age at onset and severity vary widely according to the genetic subtype, family history, and stage of growth.
Diagnosis
Leg deformities or functional limitations may become more apparent with growth, although some patients have relatively mild symptoms or are identified later.
Management
Diagnosis combines the growth pattern, physical examination, and skeletal X-ray findings and, when needed, adds genetic testing and evaluation for other skeletal disorders.
Treatment and research status
X-ray findings may vary with the subtype and stage of growth, so no single finding confirms the diagnosis, and a negative genetic test does not always exclude the disorder.
Reading the evidence
Management includes regular assessment of growth and the skeleton, evaluation of pain and function, and rehabilitation and orthopedic consultation when needed.
Key caution
Treatment focuses on symptom management and correction of deformities according to the subtype and functional problems rather than using one method to correct the entire disease group.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a glance

Metaphyseal chondrodysplasia is a group of inherited skeletal disorders involving abnormal development of the metaphyses and growth plates of the long bones.

Typical clinical features may include short stature, bowed legs, skeletal deformities, and stiffness or pain around the joints.

How the disorder works

This group includes several genetic subtypes, and inheritance patterns and associated features may differ by subtype.

When the conversion of cartilage to bone in the growth plates and metaphyses is disrupted, abnormalities in bone growth and shape can occur.

How it varies from person to person

The age at onset and severity vary widely according to the genetic subtype, family history, and stage of growth.

Overall approach to diagnosis and management

Leg deformities or functional limitations may become more apparent with growth, although some patients have relatively mild symptoms or are identified later.

Diagnosis combines the growth pattern, physical examination, and skeletal X-ray findings and, when needed, adds genetic testing and evaluation for other skeletal disorders.

Current state of treatment

X-ray findings may vary with the subtype and stage of growth, so no single finding confirms the diagnosis, and a negative genetic test does not always exclude the disorder.

Management includes regular assessment of growth and the skeleton, evaluation of pain and function, and rehabilitation and orthopedic consultation when needed.

Treatment focuses on symptom management and correction of deformities according to the subtype and functional problems rather than using one method to correct the entire disease group.

How to read clinical trials

Follow-up should track growth rate, leg alignment, joint function, pain, and postoperative changes over time, and research findings should be considered together with the subtype studied and the duration of assessment.

Points to discuss during a clinical visit

During clinical care, it is important to review the most troublesome current symptoms, changes in growth and function, family history, previous imaging and genetic tests, and the required specialist consultations and follow-up plan.

Medical information

This material is for educational purposes and does not replace individualized diagnostic or treatment guidance. Decisions about symptoms or test results should be discussed with a healthcare professional.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.